Lilly Rebuffed by Supreme Court on $194 Million Medicaid Award

The US Supreme Court let stand a $194 million award against Eli Lilly & Co. in a whistleblower suit accusing the company of engaging in Medicaid fraud by misreporting its drug prices.

Read the article here

Lisätietoja Toimitus

Toimitus

Katso myös

Ebola, hantavirus: Is the world prepared for the next pandemic?

Funding cuts in health research, and the antivaccine movement make it challenging to respond to …